Skip to content
The Policy VaultThe Policy Vault

Vesicare LSBlue Cross Blue Shield of Kansas

Treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency

Preferred products

  • darifenacin
  • oxybutynin chloride
  • trospium chloride
  • tolterodine tartrate

Initial criteria

  • Step therapy applies: patient must have tried and failed or have contraindication to preferred urinary incontinence agents prior to approval of non-preferred agents.